Barclays maintains Altria Group at Underweight, raises price target to $60 from $58

Barclays kept its Underweight rating on Altria Group but raised its price target to $60 from $58. This implies a 23.1% downside from the Oct 30 close of $78.03. Other recent analyst targets for Altria range from $72 to $83.

Original reporting
Published Nov 2, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays maintains Altria Group at Underweight, raises price target to $60 from $58 — source image
Decision brief

The 30-second read

$MONeutralLow
01

Why it matters

The modest target increase provides limited new information for traders; the stock remains significantly above the target.

02

Market read

Small analyst rating adjustment with limited immediate trading impact.

03

What to watch

Potential regulatory or litigation risks not addressed in the target change.

Relevance 6/10Novelty 5/10Timing: post‑market today

Background

Barclays maintains an Underweight stance on Altria Group (MO) while modestly raising its price target.

Company-level read

Ticker impact

$MONeutralMedium confidence
Context

Barclays raised Altria's price target to $60 from $58, indicating a modest upside despite an Underweight rating.

Expected impact

likely modest downside as market prices in the still‑low target

Evidence & confidence

Target of $60 is 23% below the recent $78 close, limiting upside and suggesting limited trader interest.

Market effects

Minor impact on tobacco sector; analyst view shift may slightly affect peers.

U.S. market only; no broader regional effect.

Limited global relevance.

Counterpoint

Investors may view the target as too low and hold off on buying.

Key entities

  • Altria Group

    U.S. tobacco company (ticker MO).

  • Barclays

    Investment bank providing the rating and price target.

Related articles

$MOHighAI 8/10

Why Did MO, GILD, XOM Stocks Surge To 52-Week Highs Last Week?

Altria (MO), Gilead (GILD), and ExxonMobil (XOM) reached 52-week highs after strong Q3 results. MO reported $1.52 EPS, raised guidance, and increased buybacks. GILD exceeded revenue/earnings expectations, boosting HIV growth outlook. XOM posted $4.23 EPS, raised dividend, and maintained buyback plan. All three stocks gained 1-3% on the day.

$MOHighAI 8/10

America’s Greatest Dividend Posts Strong Earnings

Altria (MO) reported Q3 revenue of $6.1B (+1% YoY) and EPS of $1.51 (+7% YoY), beating expectations. The company raised its full-year earnings guidance, citing strong performance. Shares rose 6% over two days and are up 33% YTD. CEO Sal Mancuso highlighted confidence in the full-year plan. Marlboro, with a 40% U.S. market share, drives most revenue. Other high-yield companies like UPS, Kraft Heinz, and General Mills face economic sensitivity and competition.

$MOMed

Goldman Sees More Upside in Altria After Strong Quarter

Goldman Sachs raised its price target for Altria (MO) to $83 from $77, citing better-than-expected Q3 earnings and revenue. Adjusted EPS was $1.52, beating estimates, and revenue reached $6.13B. Management increased its 2026 EPS growth outlook. Goldman expects continued benefits from tax drawbacks and a manufacturing agreement with Philip Morris. MO stock is up 40% year-to-date.

$MOHighAI 8/10

UBS raises Altria stock price target to $83 on strong quarter

UBS raised its price target on Altria Group (NYSE:MO) to $83, citing strong Q3 2026 revenue growth of 3.6% and raised EPS guidance. The stock trades near its 52-week high, up 43% over the past year. Altria's dividend yield is 5.79%, and it has raised dividends for 16 consecutive years. Recent earnings beat estimates, with EPS of $1.52 and revenue of $6.13 billion. Goldman Sachs and BofA Securities also raised their price targets.

$MOHighAI 8/10

What Just Happened To Altria Stock?

Altria (MO) shares rose 5.2% on October 29, 2026, after beating Q3 earnings estimates and raising its full-year guidance. The company reported adjusted earnings of $1.52 per share on $5.44 billion in revenue, exceeding forecasts. Management raised its 2026 earnings outlook to $5.66-$5.74 per share, up from prior guidance. The stock closed at $76.75, its highest in a year, with a 29.5% return over the past 12 months.